Saturday 17 October 2026
Export PRGO’s income statement to Excel — free account
Perrigo Company plc
PRGO Healthcare Drug Manufacturers Specialty & Generic
Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024. In the quarter to June 2026, revenue fell 3.17%, EPS grew 1,000.0%, free cash flow grew 18.4% and total debt fell 9.78%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
16.63
0.15
+0.91%
Follow PRGO
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 47.83 | 41.22 | 106.77 | 0.00 |
Piotroski F-Score |
4 | 4 | 6 | 4 | 7 | 4 | 6 | 6 | 9 | — |
Altman Z-Score |
(0.08) | 0.74 | 0.78 | 0.79 | 1.12 | 1.01 | 1.10 | 1.02 | 1.86 | 0.68 |
P/S ratio |
0.45 | 0.81 | 0.96 | 1.06 | 1.26 | 1.49 | 1.82 | 1.13 | 2.58 | 2.35 |
Altman Z″-Score (non-manufacturers) |
(0.37) | 1.15 | 1.05 | 1.22 | 2.12 | 1.65 | 1.53 | 1.53 | 1.76 | (0.21) |
P/FCF ratio |
12.57 | 12.28 | 13.68 | 19.76 | 649.63 | 12.95 | 27.77 | 10.59 | 18.30 | 13.74 |
P/Operating CF |
10.99 | 11.30 | 21.50 | 25.47 | (49.31) | 55.13 | 78.50 | 27.48 | 58.84 | 60.11 |
Beneish M-Score |
(3.51) | (2.83) | (2.68) | (2.52) | (2.53) | (3.19) | (2.34) | (2.73) | (2.72) | (3.77) |
Dividend Safety Score |
16 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.66 | 0.82 | 0.94 | 0.98 | 1.01 | 1.08 | 1.21 | 0.94 | 2.07 | 2.08 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 5,774.49 | 85.84 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.18 | 1.51 | 1.68 | 1.85 | 1.66 | 2.21 | 2.59 | 1.70 | 3.12 | 3.33 |
EV/EBITDA |
0.00 | 14.72 | 15.20 | 19.77 | 9.53 | 13.93 | 17.71 | 12.32 | 15.11 | 0.00 |
EV/Operating CF |
21.12 | 18.16 | 19.26 | 26.82 | 43.84 | 14.18 | 25.89 | 13.54 | 22.07 | 26.83 |
EV/FCF |
32.83 | 22.91 | 23.81 | 34.38 | 856.58 | 19.20 | 39.69 | 15.93 | 22.11 | 19.47 |
Quick Ratio |
1.13 | 1.15 | 0.94 | 1.17 | 1.59 | 0.89 | 1.20 | 1.06 | 1.26 | 0.98 |
Current Ratio |
2.76 | 2.38 | 1.79 | 2.44 | 2.43 | 2.27 | 2.04 | 1.89 | 1.96 | 1.53 |
Net Debt/EBITDA |
(4.01) | 6.83 | 6.47 | 8.41 | 2.30 | 4.53 | 5.32 | 4.13 | 2.61 | (3.30) |
Debt/Assets |
42.65% | 37.50% | 37.68% | 37.27% | 33.77% | 31.03% | 29.81% | 29.52% | 28.73% | 41.80% |
Debt/Equity |
1.24 | 0.84 | 0.85 | 0.85 | 0.68 | 0.63 | 0.58 | 0.57 | 0.54 | 0.97 |
Asset Turnover |
0.47 | 0.43 | 0.43 | 0.42 | 0.38 | 0.36 | 0.35 | 0.42 | 0.39 | 0.32 |
Operating CF/Net income |
(0.17) | (2.11) | (31.93) | (2.19) | (2.27) | (3.91) | 2.65 | 4.53 | 5.84 | (0.16) |
Capex/Depreciation |
(0.25) | (0.22) | (0.21) | (0.20) | (0.48) | (0.43) | (0.34) | (0.21) | 0.00 | 0.57 |
Interest Coverage |
(6.91) | 0.60 | 0.87 | 0.51 | 3.28 | 2.08 | 1.49 | 1.85 | 3.56 | (9.23) |
| (39.29%) | (3.78%) | (0.26%) | (2.81%) | (1.28%) | (2.84%) | 2.55% | 2.21% | 1.97% | (49.96%) | |
| (15.68%) | (1.68%) | (0.12%) | (1.31%) | (0.63%) | (1.43%) | 1.31% | 1.16% | 0.94% | (24.16%) | |
ROIC |
(11.60%) | 0.96% | 1.17% | 0.59% | 3.77% | 1.93% | 1.24% | 1.77% | 4.23% | (11.23%) |
Return on Tangible Assets |
(53.12%) | (7.29%) | (0.59%) | (5.55%) | (2.20%) | (6.22%) | 6.36% | 5.97% | 5.40% | (218.19%) |
Average Days of Receivables |
52.59 | 53.61 | 57.98 | 57.16 | 57.58 | 52.99 | 117.26 | 82.78 | 83.45 | 81.29 |
Research and Development Expense of Revenue |
2.24% | 2.57% | 2.63% | 2.77% | 2.95% | 2.98% | 3.08% | 4.62% | 3.39% | 3.48% |
Selling, General and Administrative Expense of Revenue |
24.82% | 25.44% | 27.38% | 27.18% | 26.85% | 27.13% | 28.35% | 23.79% | 23.18% | 22.83% |
Intangible Assets out of Total Assets |
0.52 | 0.60 | 0.60 | 0.62 | 0.49 | 0.49 | 0.63 | 0.63 | 0.65 | 0.71 |
Share Based Compensation of Revenue |
1.28% | 1.47% | 1.48% | 1.23% | 1.45% | 1.43% | 1.35% | 0.80% | 0.89% | 0.44% |
Graham Net Nets |
(1.45) | (0.81) | (0.71) | (0.73) | (0.27) | (0.44) | (0.39) | (0.45) | (0.21) | (0.41) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 32.20 | 29.50 | 28.63 | 0.00 |
Earnings Yield |
(73.85%) | (4.86%) | (0.30%) | (2.73%) | (0.87%) | (2.68%) | 2.09% | 2.43% | 0.94% | (29.67%) |
Free Cash Flow Yield |
7.96% | 8.14% | 7.31% | 5.06% | 0.15% | 7.72% | 3.60% | 9.44% | 5.47% | 7.28% |
Revenue per Share |
30.71 | 31.83 | 34.41 | 33.10 | 30.98 | 30.04 | 28.46 | 34.34 | 34.76 | 36.85 |
Operating CF per Share |
1.72 | 2.64 | 3.00 | 2.28 | 1.17 | 4.67 | 2.85 | 4.30 | 4.91 | 4.57 |
Capex per Share |
(0.63) | (0.55) | (0.57) | (0.50) | (1.11) | (1.22) | (0.99) | (0.65) | (0.01) | 1.73 |
Free Cash Flow per Share |
1.09 | 2.09 | 2.42 | 1.78 | 0.06 | 3.45 | 1.86 | 3.66 | 4.90 | 6.30 |
Cash per Share |
3.84 | 4.07 | 5.55 | 4.47 | 13.96 | 4.64 | 2.61 | 4.00 | 4.77 | 4.34 |
Shareholders Equity per Share |
21.19 | 31.44 | 35.24 | 36.00 | 38.56 | 41.55 | 42.68 | 41.13 | 43.36 | 41.57 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
21.19 | 31.44 | 35.24 | 36.00 | 38.56 | 41.55 | 42.68 | 41.13 | 43.36 | 41.57 |
Free Cash Flow |
150.70 | 287.70 | 328.00 | 239.70 | 8.00 | 469.90 | 253.00 | 504.10 | 697.60 | 902.40 |
Working Capital |
1,784.50 | 1,437.70 | 1,246.60 | 1,606.30 | 2,272.00 | 1,751.50 | 1,394.80 | 1,364.80 | 1,383.60 | 969.00 |
Capital Expenditures |
(87.80) | (75.20) | (77.50) | (67.60) | (148.30) | (166.30) | (134.80) | (88.90) | (1.30) | 247.50 |
Net Current Asset Value |
(2,802.30) | (2,846.40) | (3,208.30) | (3,455.30) | (1,414.10) | (2,699.80) | (2,766.70) | (2,413.10) | (2,638.60) | (5,107.20) |
EV/EBIT |
0.00 | 58.39 | 51.42 | 104.46 | 16.70 | 34.01 | 57.47 | 33.96 | 25.79 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.04 | 0.03 | 0.02 | 0.00 | (0.05) |
Price to Operating Income |
0.00 | 31.29 | 29.55 | 60.02 | 12.66 | 22.95 | 40.22 | 22.58 | 21.34 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.39 | 0.36 | 0.39 | 0.36 | 0.36 | 0.44 | 0.43 | 0.50 | 0.51 | 0.50 |
Cash ROIC |
2.12% | 3.39% | 3.42% | 2.51% | 0.08% | 4.77% | 2.66% | 5.33% | 6.85% | 7.29% |
Accounts Receivable Turnover |
6.78 | 6.33 | 6.48 | 6.60 | 6.64 | 4.45 | 3.34 | 4.29 | 4.29 | 4.47 |
Accounts Payable Turnover |
5.69 | 5.82 | 5.86 | 6.32 | 6.31 | 5.34 | 4.90 | 6.27 | 6.44 | 6.28 |
Inventory Turnover |
2.47 | 2.55 | 2.60 | 2.76 | 2.62 | 2.56 | 2.64 | 3.44 | 3.70 | 3.81 |
Average Days of Payables |
62.78 | 63.85 | 58.60 | 65.45 | 55.13 | 63.56 | 77.94 | 59.77 | 55.39 | 53.32 |
Days of Inventory on Hand |
152.03 | 139.49 | 139.97 | 140.13 | 136.78 | 149.11 | 144.92 | 110.50 | 99.27 | 89.87 |
Average Receivables |
627.55 | 690.95 | 718.35 | 675.00 | 623.20 | 918.35 | 1,158.15 | 1,101.95 | 1,153.40 | 1,182.50 |
Average Payables |
484.85 | 486.45 | 507.50 | 474.25 | 431.40 | 485.90 | 497.55 | 462.55 | 460.95 | 513.75 |
Average Inventory |
1,115.40 | 1,111.35 | 1,145.60 | 1,085.25 | 1,039.80 | 1,013.35 | 922.65 | 842.45 | 800.95 | 846.85 |
Average Assets |
9,091.45 | 10,228.40 | 10,913.20 | 10,721.50 | 10,957.05 | 11,394.90 | 11,142.40 | 11,306.10 | 12,749.45 | 16,609.85 |
Average Common Equity |
3,627.45 | 4,543.65 | 4,805.00 | 4,996.90 | 5,403.40 | 5,729.60 | 5,736.10 | 5,919.35 | 6,064.10 | 8,032.20 |
Columns are period end dates